Search

Competing Interests: None disclosed.

Competing Interests: None disclosed.

Competing Interests: Dr Vesely's spouse is an employee of Regeneron Pharmaceuticals, the maker of dupilumab. Dr Damsky is a consultant for Pfizer, Eli Lilly, and TWi Biotechnology, has received research funding from Pfizer, and receives licensing fees from EMD/Millipore/Sigma. Dr Peterson has no conflicts of interest to declare.

Competing Interests: Dr Lebwohl is an employee of Mount Sinai Dermatology, which receives research funds from Regeneron-Sanofi, 10.13039/100006483Abbvie, 10.13039/100004336Novartis, 10.13039/100002429Amgen, Eli Lilly, 10.13039/100011110UCB Inc, 10.13039/100005205Janssen Research and Development, LLC, and Ortho Dermatologics. He has been the principal investigator for numerous clinical trials but has no personal financial gain. Authors Wei, Kresch, and Elbogen have no conflicts of interest to declare.

Competing Interests: None disclosed.

Competing Interests: Saakshi Khattri is an employee of Mount Sinai and a consultant for Abbvie, Eli Lilly, Glenmark, Ichnos Sciences, Janssen, and Novartis. She serves on the Advisory Boards for Eli Lilly, Glenmark, Ichnos Sciences, Janssen, Novartis, and UCB. Merav Koschitzky, Ryan Rivera-Oyola, Kathryn Tan, and Maria Rosa Noliza Encarnacion have no relevant conflicts of interest to declare.